Basal forebrain afferent projections modulating cortical acetylcholine, attention, and implications for neuropsychiatric disorders

Annals of the New York Academy of Sciences

Volumn 877, Issue , 1999, Pages 368-382

  Sarter, Martin ^a   Bruno, John P ^a   Turchi, Janita ^a  

^a OHIO STATE UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ACETYLCHOLINE; BENZODIAZEPINE RECEPTOR AFFECTING AGENT; DOPAMINE; DOPAMINE 1 RECEPTOR BLOCKING AGENT; DOPAMINE 2 RECEPTOR BLOCKING AGENT;

ACETYLCHOLINE RELEASE; ATTENTION; BRAIN CORTEX; CHOLINERGIC NERVE CELL; COGNITION; COMPULSION; CONFERENCE PAPER; DRUG DEPENDENCE; FOREBRAIN; GABAERGIC SYSTEM; HUMAN; MENTAL DISEASE; NEUROPSYCHIATRY; NONHUMAN; NUCLEUS ACCUMBENS; RAT; SCHIZOPHRENIA; SENSORY NERVE;

EID: 0032780061     PISSN: 00778923     EISSN: None     Source Type: Book Series    
DOI: 10.1111/j.1749-6632.1999.tb09277.x     Document Type: Conference Paper

References (73)

1. 1. Heimer, L., J. De Olmos, G.F. Alheid & L. Zaborszky. 1991. "Perestroika" in the basal forebrain: opening the border between neurology and psychiatry. Prog. Brain Res. 87: 109-165.
2. 2. Tandon, R. & J.F. Greden. 1989. Cholinergic hyperactivity and negative schizophrenic symptoms. Arch. Gen. Psychiatry 46: 745-753.
3. 3. Alheid, G.F. & L. Heimer. 1988. New perspectives in basal forebrain organization of special relevance for neuropsychiatrie disorders: the striatopallidal, amygdaloid, and corticopetal components of substantia innominata. Neuroscience 27: 1-39.
4. 4. Alheid, G.F. & L. Heimer. 1996. Theories of basal forebrain organization and the "emotional motor system." Prog. Brain Res. 107: 461-484.
5. 5. Sarter, M. & J.P. Bruno. 1997. Dopamine's role. Science 278: 1549-1550.
6. 6. Sarter, M., G.G. Berntson & J.T. Cacioppo. 1996. Brain imaging and cognitive neuroscience: toward strong inference in attributing function to structure. Am. Psychol. 51: 13-21.
7. 7. Sarter, M. 1994. Neuronal mechanisms of the attentional dysfunctions in senile dementia and schizophrenia: two sides of the same coin? Psychopharmacology 114: 539-550.
8. 8. Sarter, M. & J.P. Bruno. 1997. Cognitive functions of cortical acetylcholinc: toward a unifying hypothesis. Brain Res. Rev. 23: 28-46.
9. 9. Sarter, M. & J.P. Bruno, 1999. Abnormal regulation of corticopetal cholinergic neurons and impaired information processing in neuropsychiatrie disorders. Trends Neurosci. 22: 67-74.
10. 10. Sarter, M. & J.P. Bruno. 1998. Cortical acetylcholine, reality distortion, schizophrenia and Lewy body dementia: too much or too little acetylcholine? Brain Cogn. 38: 297-316.
11. 11. Everitt, B.J. & T.W. Robins. 1997. Central cholinergic systems and cognition. Annu. Rev. Psychol. 48: 649-684.
12. 12. Torres, E.M., T.A. Perry, A. Blokland, S. Wilkinson, R.G. Wiley, D.A. Lappis & S.B. Dunnett, 1994. Behavioral, histochemical and biochemical consequences of selective immunolesions in discrete regions of the basal forebrain cholinergic system. Neuroscience 63: 95-122.
13. 13. Muir, J.L., B.J. Everitt & T.W. Robbins. 1994. AMPA-induced excitotoxic lesions of the basal forebrain: a significant role for the cortical cholinergic system in attentional function. J. Neurosci. 14: 2313-2326.
14. 14. Chiba, A.A., D.J. Bucci, P.C. Holland & M. Gallagher. 1995. Basal forebrain cholinergic lesions disrupt increments but not decrements in conditioned stimulus processing. J. Neurosci. 15: 7315-7322.
15. 15. McGaughy, J., T. Kaiser & M. Sarter. 1996. Behavioral vigilance following infusions of 192 IgG-saporin into the basal forebrain: selectivity of the behavioral impairment and relation to cortical AChE-positive fiber density. Behav. Neurosci. 110: 247-265.
16. 16. Turchi, J. & M. Sarter. 1997. Cortical acetylcholine and processing capacity: effects of cortical cholinergic deafferenlation on crossmodal divided attention in rats. Cogn. Brain Res. 6: 147-158.
17. 17. Sarter, M., J.P. Bruno, B. Givens, H. Moore, J. McGaughy & K. McMahon. 1996. Neuronal mechanisms mediating drug-induced cognition enhancement: cognitive activity as a necessary intervening variable. Cogn. Brain Res. 3: 329-343.
18. 18. Gill, T.M., D.M. Kent, M. Sarter & B. Givens. 1997. Behavioral correlates of neural activity recorded from the rodent medial prefrontal cortex during sustained visual attention. Soc. Neurosci. Abstr. 23: 716.10.
19. 19. Himmelheber, A.M., M. Sarter & J.P. Bruno. 1997. Opérant performance and cortical acetylcholine release: role of response rate, reward density, and non-contingent stimuli. Cogn. Brain Res. 6: 23-36.
20. 20. Bruno, J.P., M. Sarter, M. Arnold & A.M. Himmelheber. 1999, In vivo neurochemical correlates of cognitive processes: methodological and conceptual challenges. Rev. Neurosci. 10: 25-48.
21. 21. Cowan, N. 1995. Attention and memory. An integrated framework. Oxford University Press. New York.
22. 22. Semba, K., P.B. Rainer, E.G. McGeer & H.C. Fibiger. 1989. Brainslem afferents to the magnocellular basal forebrain studies by axonal transport, immunohistochemistry, and electrophysiology in the rat. J. Comp. Neurol. 267: 433-453.
23. 23. Zaborszky, L., W.E. Cullinan & V.N. Luine. 1993, Catecholaminergic-cholinergic interaction in the basal forebrain. Prog. Brain Res. 98: 31-49.
24. 24. Jones, B.E. & A.C. Cuello. 1989. Afferents to the basal forcbrain cholinergic cell area from pontomesencephalic-catecholamine, serotonin, and acetylcholine-neurons. Neuroscience 31: 37-61.
25. 25. Consolo, S., R. Bertorelli, G.L. Forloni & L.L. Butcher. 1990. Cholinergic neurons of the pontomesenccphalic tegmentum release acetylcholine in the basal nuclear complex of freely moving rats. Neuroscience 37: 717-723.
26. 26. Steriade, M. & G. Buzsaki. 1990. Parallel activation of thalamic and cortical neurons by brainstem and basal forebrain cholinergic systems. In Brain Cholinergic Systems. M. Stcriade & D. Biesold, Eds.: 3-62. Oxford University Press. Oxford.
27. 27. Robbins, T.W. & B.J. Everitt. 1995, Arousal systems and attention. In The Cognitive Neurosciences. M. Gazzaniga, Ed.: 703-720. MIT Press. Cambridge, MA.
28. 28. Mesulam, M-M. 1995. Cholinergic pathways and the ascending reticular activating system of the human brain. Ann. N.Y. Acad. Sci. 757: 169-179.
29. 29. McGaughy, J., M. Sandstrom, S. Ruland, J.P. Bruno & M. Sarter. 1997. Lack of effects of lesions of the dorsal noradrenergic bundle on behavioral vigilance. Behav. Neurosci. 111: 646-652.
30. 30. Carli, M., T.W. Robbins, J.L. Evenden & B.J. Everitt. 1983. Effects of lesions of ascending noradrenergic neurones on performance of a 5-choice serial reaction task in rats: implications for theories of dorsal noradrenergic bundle function based on selective attention and arousal. Behav. Brain Res. 9: 361-380.
31. 31. Aston-Jones, G., J. Rajkwoski, P. Kubiak, R.J. Valentino & M.T. Shipley. 1996. Role of the locus coeruleus in emotional activation. Prog. Brain Res. 107: 379-402.
32. 32. Fort, P., A. Khateb, A. Pegna, M. Mühlethaler & B.E. Jones. 1995. Noradrenergic modulation of cholinergic nucleus basalis neurons demonstrated by in vitro pharmacological and immunohistochemical evidence in the guinea pig brain. Eur. J. Neurosci. 7: 1502-1511.
33. 33. Berntson, G.G., M. Sarter & J.T. Cacioppo. 1998. Anxiety and cardiovascular reactivity, the basal forebrain cholinergic system. Behav. Brain Res. 94: 225-248.
34. 34. Cape, E.G. & B.E. Jones. 1998, Differential modulation of high frequency γ-electroencephalogram activity and sleep-wake state by noradrenaline and serotonin microinjections into the region of cholinergic basalis neurons. J. Neurosci. 18: 2653-2666.
35. 35. Zaborszky, L., L. Heimer, F. Eckenstein & C. Leranth. 1986. GABAergic input to cholinergic forebrain neurons: an ultrastructural study using retrograde tracing of HRP and double immunolabeling. J. Comp. Neurol. 250: 282-295.
36. 36. Ingham, C.A., J.P. Bolam & A.D. Smith. 1988. GABA-immunoreactive synaptic boutons in the rat basal forebrain: comparison of neurons that project to the neocortex with pallidosubthalamic neurons. J. Comp. Neurol. 273: 263-282
37. 37. Mogenson, G.J., L.W. Swanson & M. Wu. 1983. Neural projections from nucleus accumbens to globus pallidus, substantia innominata, and lateral preoptic-lateral hypothalamic area: an anatomical and electrophysiological investigation in the rat. J. Neurosci. 3: 189-202.
38. 38. Sarter, M. & J.P. Bruno. 1994. Cognitive functions of cortical ACh [acetylcholine]: lessons from studies on the trans-synaptic modulation of activated efflux. Trends Neurosci. 17: 217-221.
39. 39. Inglis, F.M., J.C. Day & H.C. Fibiger. 1994. Enhanced acetylcholinc release in hippocampus and cortex during the anticipation and consumption of a palatable meal. Neuroscience 62: 1049-1056.
40. 40. Holley, L.A., J. Turchi, C. Apple & M. Sarter. 1995. Dissociation between the attentional effects of infusions of a benzodiazepine receptor agonist and an inverse agonist into the basal forebrain. Psychopharmacology 120: 99-108.
41. 41. McGaughy, J., J. Turchi & M. Sarter. 1994. Crossmodal divided attention in rats: effects of chlordiazepoxide and scopolamine. Psychopharmacology 115: 213-220.
42. 42. Evenden, J.L., H.M. Marston, G.H. Jones, V. Giardini, L. Lenard, B.J. Everitt & T.W. Robbins. 1989. Effects of excitotoxic lesions of the substantia innominata, ventral and dorsal globus pallidus on visual discrimination acquisition, performance and reversal in the rat. Behav. Brain Res. 32: 129-149.
43. 43. Dudchenko, P. & M. Sarter. 1992. Failure of chlordiazepoxide to reproduce the behavioral effects of muscimol administered into the basal forebrain. Behav Brain Res. 47: 202-205.
44. 44. Sarter, M., J.P. Bruno & P. Dudchenko. 1990. Activating the damaged basal forebrain cholinergic system: tonic stimulation versus signal amplification. Psychopharmacology 101: 1-17.
45. 45. Duka, T., V. Edelmann, B. Schütt & R. Dorow. 1988. β-carbolines as tools in memory research. Human data with the β-carboline ZK 93426. In Benzodiazepine Receptor Ligands, Memory and Information Processing. I. Hindmarch, H. Ott & T. Roth, Eds.: 246-251. Springer. New York.
46. 46. Furley, M.L., P. Petrini, J.V. Haxby, G.E. Alexander, H.C. Lee, J. Van Meter, C.L. Grady, U. Shetty, S.I. Rapoport, M.B. Schapiro & U. Freo. 1997. Cholinergic stimulation alters performance and task-specific regional cerebral blood flow during working memory. Proc. Natl. Acad. Sci. USA 94: 6512-6516.
47. 47. Sahakian, B.J., A.M. Owen, N.J. Morant, S.E. Eagger, S. Boddington, L. Crayton, H.A. Crockford, M. Crooks, K. Hill & R. Levy, 1993. Further analysis of the cognitive effects of tetrahydroaminoacridine (THA) in Alzheimer's disease: assessment of attentional and mnemonic function using CANTAB. Psychopharmacology 110: 395-401.
48. 48. Gray, J.A. 1998. Integrating schizophrenia. Schizophr. Bull. 24: 249-266.
49. 49. Smith, C.G., R.J. Beninger, P.E. Mallet, K. Jhamandas & R. Boegman. 1994. Basal forebrain injections of the benzodiazepine partial inverse agonist F 7142 enhance memory of rats in the double Y-maze. Brain Res. 666: 61-67.
50. 50. Zaborszky, L., W.E. Cullinan & A. Braun. 1991. Afferents to basal forebrain cholinergic projection neurons: an update. In The Basal Forebrain. Anatomy to Function. T.C. Napier, P.W. Kalivas & I. Hanin, Eds.: 43-100. Plenum Press. New York.
51. 51. Zaborszky, L. & W.E. Cullinan. 1992. Projections from the nucleus accumbens to cholincrgic neurons of the ventral pallidum: a correlated light and electron microscopic double-immunolabeling study in the rat. Brain Res. 570: 92-101.
52. 52. Pare, D. & Y. Smith. 1994. GABAergic projections from the intercalated cell masses of the amygdala to the basal forebrain in cats. J. Comp. Neurol. 344: 33-49.
53. 53. Bourdelais, A. & P. Kalivas, 1990. Amphetamine lowers extracellular GABA concentrations in the ventral pallidum. Brain Res. 516: 132-136.
54. 54. Bourdelais, A. & P. Kalivas. 1992. Apomorphine decreases extracellular GABA in the ventral pallidum of rats with 6-OHDA lesions in the nucleus accumbens. Brain Res. 577: 306-311.
55. 2 receptors in the ventral striopallidal system. Implications for the treatment of schizophrenia. Neuroscience 63: 765-773.
56. 56. Swerdlow, N.R., D.L. Braff & M.A. Geyer. 1990. GABAergic projection from the nucleus accumbens to ventral pallidum mediates dopamine-induced sensorimotor gating deficits of acoustic startle in rats. Brain Res. 532: 146-150.
57. 57. Hooks, M.S. & P.W. Kalivas. 1995. The role of mesoaccumbens-pallidal circuitry in novelty-induced behavioral activation. Neuroscience 64: 587-597.
58. 58. Shreve, P.E. & N.J. Uretsky. 1988. Effect of GABAergic transmission in the subpallidal region on the hypermotility response to the administration of excitatory amino acids and picrotoxin into the nucleus accumbens. Neuropharmacology 12: 1271-1277.
59. 59. Imperato, A., S. Puglisi-Allegra, M.G. Scrocco, P. Casolini, S. Bacchi & L. Angelucci. 1992. Cortical and limbic dopamine and acetylcholine release as neurochemical correlates of emotional arousal in both aversive and non-aversive environmental changes. Neurochem. Int. 20: 265S-270S.
60. 60. Day, J. & H.C. Fibiger, 1992. Dopaminergic regulation of cortical acetylcholine release. Synapse 12: 281-286.
61. 61. Day, J., C.S. Tham & H.C. Fibiger. 1994. Dopamine depletion attenuates amphetamine-induced increases in cortical ACh release. Eur. J. Pharmacol. 263: 285-292.
62. 62. Darracq, L., G. Blanc, J. Glowinksi & J.P. Tassin. 1998. importance of the noradrenaline-dopamine coupling in the locomotor activating effects of D-amphetamine. J. Neurosci. 18: 2729-2739.
63. 63. Killcross, A.S. & T.W. Robbins. 1993. Differential effects of intra-accumbens and systemic amphetamine on latent inhibition using an on-baseline, within-subject conditioned suppression paradigm. Psychopharmacology 110: 479-489.
64. 64. Robinson, R.E. & J.B. Becker. 1986. Enduring changes in brain and behavior produced by chronic amphetamine administration: a review and evaluation of animal models of amphetamine psychosis. Brain Res. Rev. 11: 157-198.
65. 65. Moore, H., S. Stuckman, M. Sarter & J.P. Bruno. 1995. Stimulation of cortical acetylcholine efflux by FG 7142 measured with repeated microdialysis sampling. Synapse 21: 324-331.
66. 66. Moore, H., J. Fadel, M. Sarter & J.P. Bruno. 1999. Role of accumbens and cortical dopamine receptors in the regulation of cortical acetylcholine release. Neuroscience. 88: 811-822.
67. 67. Borger, B.A., J.D. Elsworth & R.H. Roth. 1995. Selective increase in dopamine utilization in the shell subdivision of the nucleus accumbens by the benzodiazepine inverse agonist FG 7142. J. Neurochem. 65: 770-774.
68. 68. Murphy, B.L., A.F.T. Arnsten, P.S. Goldman-Rakic & R.H. Roth. 1996. Increased dopamine turnover in the prefrontal cortex impairs spatial working memory performance in rats and monkeys. Proc. Natl. Acad. Sci. USA 93: 1325-1329.
69. 69. Gray, J.A., M.H. Joseph, D.R. Hemsley, A.M.J. Young, E.C. Warburton, P. Boulenguez, G.A. Grigoryan, S.L. Peters, J.N.P. Rawlins, C.T. Taib, B.K. Yee, H. Cassaday, I. Weiner, G. Gal, O. Gusak, D. Joel, E. Shadach, U. Shalev, R. Tarrasch & J. Feldon. 1995. The role of mesolimbic dopaminergic and retrohippocampal afferents to the nucleus accumbens in latent inhibition: implications for schizophrenia. Behav. Brain Res. 71: 19-31.
70. 70. Kalivas, P. & J. Stewart. 1991. Dopamine transmission in the initiation and expression of drug-and stress-induced sensitization of motor activity. Brain Res. Rev. 16: 223-244.
71. 71. DiChiara, G. 1998. A motivational learning hypothesis of the role of mcsolimbic dopamine in compulsive drug use. J. Psychopharmacol. 12: 54-67.
72. 72. Deller, T. & M. Sarter. 1998. Effects of repeated administration of amphetamine on behavioral vigilance: evidence for "sensitized" attcntional impairments. Psychopharmacology 137: 410-414.
73. 73. Robinson, T.E. & K.C. Berridge. 1993. The neural basis of drug craving: an incentive-sensitization theory of addiction. Brain Res. Rev. 18: 247-291.